Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy

Immune checkpoint inhibitors are used to restore or augment antitumor immune responses and show great promise in the treatment of melanoma and other types of cancers. However, only a small percentage of patients are fully responsive to immune checkpoint inhibition, mostly due to tumor heterogeneity...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marisa Schmitt, Tobias Sinnberg, Heike Niessner, Andrea Forschner, Claus Garbe, Boris Macek, Nicolas C. Nalpas
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/91ad1cf1ba114fcb9bb863931ff9ce55
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!